Cargando…

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis

We investigated a patient who developed multiple sclerosis (MS) during treatment with the CTLA4‐blocking antibody ipilimumab for metastatic melanoma. Initially he showed subclinical magnetic resonance imaging (MRI) changes (radiologically isolated syndrome). Two courses of ipilimumab were each follo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerdes, Lisa Ann, Held, Kathrin, Beltrán, Eduardo, Berking, Carola, Prinz, Jörg C., Junker, Andreas, Tietze, Julia K., Ertl‐Wagner, Birgit, Straube, Andreas, Kümpfel, Tania, Dornmair, Klaus, Hohlfeld, Reinhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129566/ https://www.ncbi.nlm.nih.gov/pubmed/27351142 http://dx.doi.org/10.1002/ana.24715

Ejemplares similares

Clonality of CD4(+) Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
por: Arakawa, Akiko, et al.
Publicado: (2019)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations
por: Schuh, Elisabeth, et al.
Publicado: (2015)

Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies
por: Mortazavi, Matin, et al.
Publicado: (2021)

Communication of CD8(+) T cells with mononuclear phagocytes in multiple sclerosis
por: Konjevic Sabolek, Matea, et al.
Publicado: (2019)

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
por: Spadaro, Melania, et al.
Publicado: (2016)

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
por: Schuh, Elisabeth, et al.
Publicado: (2014)

DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis
por: Souren, Nicole Y., et al.
Publicado: (2019)

Novel approaches for identifying target antigens of autoreactive human B and T cells
por: Dornmair, Klaus, et al.
Publicado: (2009)

Immune signatures of prodromal multiple sclerosis in monozygotic twins
por: Gerdes, Lisa Ann, et al.
Publicado: (2020)

An expanded parenchymal CD8+ T cell clone in GABA(A) receptor encephalitis
por: Bracher, Aline, et al.
Publicado: (2020)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer
por: Dhodapkar, Kavita, et al.
Publicado: (2014)

First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021)

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
por: Du, Xuexiang, et al.
Publicado: (2018)

Impact of CTLA-4 checkpoint antibodies on ligand binding and Transendocytosis
por: Williams, Cayman, et al.
Publicado: (2022)

Inclusion Body Myositis: Laser Microdissection Reveals Differential Up-Regulation of IFN-γ Signaling Cascade in Attacked versus Nonattacked Myofibers
por: Ivanidze, Jana, et al.
Publicado: (2011)

A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model
por: Kendirli, Arek, et al.
Publicado: (2023)

Analysis of the Paired TCR α- and β-chains of Single Human T Cells
por: Kim, Song-Min, et al.
Publicado: (2012)

Delayed diagnosis of extraovarian teratoma in relapsing anti-NMDA receptor encephalitis
por: Kümpfel, Tania, et al.
Publicado: (2016)

Plasma lipidomics of monozygotic twins discordant for multiple sclerosis
por: Penkert, Horst, et al.
Publicado: (2020)

Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement
por: Schuh, E, et al.
Publicado: (2015)

TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma
por: Khanolkar, Rahul C., et al.
Publicado: (2022)

Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
por: Le Mercier, Isabelle, et al.
Publicado: (2015)

CTLA-4 checkpoint blockade in breast cancer, a case in point report
por: Dellepiane, Chiara, et al.
Publicado: (2015)

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
por: Qin, Shuang, et al.
Publicado: (2019)

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Computational design of a cyclic peptide that inhibits the CTLA4 immune checkpoint
por: Thakkar, Ravindra, et al.
Publicado: (2023)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Inflammatory markers in autoimmunity induced by checkpoint inhibitors
por: Husain, Beate, et al.
Publicado: (2021)

MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury
por: Pomschar, Andreas, et al.
Publicado: (2013)

Correction: MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury
por: Pomschar, Andreas, et al.
Publicado: (2013)

αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell–related features
por: Held, Kathrin, et al.
Publicado: (2015)

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?
por: Wessely, Anja, et al.
Publicado: (2020)

Immune Checkpoint Molecules in Reproductive Immunology
por: Miko, Eva, et al.
Publicado: (2019)

Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy
por: Hailemichael, Yared, et al.
Publicado: (2014)

Checkpoint inhibition of PD-L1 and CTLA-4 in a child with refractory acute leukemia
por: Broglie, Larisa, et al.
Publicado: (2019)

Constitutive reduction in the checkpoint inhibitor, CTLA-4, does not accelerate SLE in NZM 2328 mice
por: Stohl, William, et al.
Publicado: (2019)

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
por: Clavijo, Paul E., et al.
Publicado: (2017)

Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models
por: Maruoka, Yasuhiro, et al.
Publicado: (2020)

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients
por: Karabon, L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b64jmo3pv425j3nv8mim9d75jf